Provider-supervised dosing and lifestyle coaching improve outcomes substantially
These medications are driving the market, supported by strong intellectual property laws, extensive clinical research networks, and comprehensive payer reimbursement systems that facilitate rapid market uptake
There has been increased interest in time-restricted eating and intermittent fasting to improve metabolic variables, although with mixed, and modest, results
Address Misconceptions Head-On Despite widespread adoption, GLP-1s remain misunderstood
Semaglutide GLP-1 has a lot of potential for patients who are struggling with weight loss
For older adults or those with coronary artery disease, lower starting doses with gradual titration are recommended